IN A NUTSHELL
John Amory is developing innovative forms of male contraception to give men a new option for taking reproductive responsibility and prevent unintended pregnancies.
Male reproductive health expert John Amory
is leading research into novel options for male contraception, male infertility and hypergonadism. In particular, he is currently examining the potential of using inhibitors of testicular retinoic acid biosynthesis as reversible male contraceptives. John has published more than 130 peer-reviewed papers in the field of male reproduction and serves on the Advisory Board of the Male Contraception Initiative. He is currently Professor of Medicine and Section Head of General Internal Medicine at the University of Washington, where he works as an attending physician on the inpatient medicine wards and in the outpatient General Internal Medicine and Men's Health Clinics.
Male Contraception, 2016.
PopSci Q&A: The Quest for a Male Contraceptive.